Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Pharmaceutical Chemicals
EuroAPI to acquire oligonucleotide producer BianoGMP
by Michael McCoy
August 31, 2023
| A version of this story appeared in
Volume 101, Issue 29
The pharmaceutical chemical maker EuroAPI is acquiring BianoGMP, an oligonucleotide producer, for about $11 million. BianoGMP, which has its roots in Friedrich Schiller University, produces oligos in small quantities for early-phase drug clinical trials. EuroAPI says BianoGMP’s facility in Gera, Germany, will complement its own, larger oligo plant in Frankfurt, Germany, where it is spending about $20 million on an expansion. EuroAPI estimates that the market for oligos in drug development is growing by 12–14% per year.
Chemical & Engineering News
ISSN 0009-2347
Copyright © 2024 American Chemical Society
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X